Back to top
more

UnitedHealth Group (UNH)

(Real Time Quote from BATS)

$566.25 USD

566.25
1,619,777

+0.22 (0.04%)

Updated Oct 18, 2024 12:46 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (233 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Boston Scientific (BSX) Gains from New Buyouts, FX Issue Ails

by Zacks Equity Research

Boston Scientific (BSX) is currently looking forward to launching its arterial and venous offerings in the second half of 2022.

Abbott (ABT) FreeStyle Libre 3 System's Study Outcome Favorable

by Zacks Equity Research

Abbott's (ABT) FreeStyle Libre 3 system is the first and only 14-day CGM system with an overall MARD of 7.9%.

Here's Why You Should Retain Quest Diagnostics (DGX) Stock Now

by Zacks Equity Research

Investors are optimistic about Quest Diagnostics (DGX) on a strong recovery in the base business and the raised 2022 outlook.

LabCorp (LH) to Enhance Access to OmniSeq INSIGHT via New Program

by Zacks Equity Research

LabCorp's (LH) new sponsored lung cancer program will expand access to comprehensive genomic testing for NSCLC patients to guide informed treatment decisions.

Zacks Industry Outlook Highlights UnitedHealth Group Anthem, Humana, Centene, and Select Medical

by Zacks Equity Research

UnitedHealth Group, Anthem, Humana, Centene, and Select Medical are part of Zacks Industry Outlook article.

Here's Why You Should Retain Bruker (BRKR) Stock for Now

by Zacks Equity Research

Investors are optimistic about Bruker (BRKR) on strength across the BSI and BEST businesses.

Phibro (PAHC) Business Hurt by Macro Issues, FX Fluctuations

by Zacks Equity Research

The increase in raw material costs and freight costs continues to pose challenges for Phibro (PAHC).

Here's Why Investors Should Retain Omnicell (OMCL) Stock Now

by Zacks Equity Research

Investors are optimistic about Omnicell's (OMCL) better-than-expected results and new launches.

Veeva Systems (VEEV) Beats on Q1 Earnings, Ups FY23 View

by Zacks Equity Research

Veeva Systems' (VEEV) fiscal Q1 results reflect impressive performances by both of its segments.

The Zacks Analyst Blog Highlights 3M, Cigna, UnitedHealth Group, Exxon Mobil, and ConocoPhillips

by Zacks Equity Research

3M, Cigna, UnitedHealth Group, Exxon Mobil, and ConocoPhillips are part of Zacks top Analyst Blog

NEOGEN (NEOG) Launches Insecticide for Poultry Producers

by Zacks Equity Research

NEOGEN's (NEOG) insect control solution for poultry producers is the latest addition to the company's Prozap product line.

Debasmita Chatterjee headshot

5 HMO Stocks Set to Gain From Membership Growth, M&A Strategy

by Debasmita Chatterjee

Rising membership and a rapidly growing aging U.S. population are likely to drive the performances of the Zacks Medical-HMO industry players. UNH, ANTM, HUM, CNC and SEM are poised to benefit from improved operational efficiencies.

Insulet (PODD) to Expand Base in Malaysia With New Facility

by Zacks Equity Research

The new manufacturing facility by Insulet (PODD) is set to have approximately 400,000 square feet of manufacturing space.

UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

UnitedHealth Group (UNH) closed at $492.55 in the latest trading session, marking a -0.85% move from the prior day.

Here's Why You Should Retain Thermo Fisher (TMO) for Now

by Zacks Equity Research

Investors are optimistic about Thermo Fisher's (TMO) robust y/y revenue growth in the Analytical Instruments, and the Laboratory Products and Biopharma Services segments.

Illumina's (ILMN) GRAIL to Assess Galleri Test With New Deal

by Zacks Equity Research

Illumina (ILMN) GRAIL's recent collaboration is part of REFLECTION, a real-world observational study assessing the performance of the Galleri MCED test in clinical settings.

Nalak Das headshot

Volatility Reigns Supreme on Wall Street: Top 5 Picks for June

by Nalak Das

We have narrowed our search to five U.S. corporate behemoths (market capital > $50 billion). These are: MMM, CI, UNH, XOM and COP.

Company News for June 1, 2022

by Zacks Equity Research

Companies in The News Are: AMZN, QCOM, UNH, AMC

Factors that Make UnitedHealth Group (UNH) an Attractive Bet Now

by Zacks Equity Research

UnitedHealth Group (UNH) continues to benefit from sustained top-line growth, a growing membership, and a strong cash position.

Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for VIG

Veeva Systems (VEEV) Vault CTMS to Aid Clinical Trial Management

by Zacks Equity Research

Veeva System's (VEEV) Vault CTMS to streamline complex trial processes for more than 150 companies.

Are Medical Stocks Lagging Assertio (ASRT) This Year?

by Zacks Equity Research

Here is how Assertio (ASRT) and UnitedHealth Group (UNH) have performed compared to their sector so far this year.

Hologic (HOLX) Gets CE Mark for Fusion Molecular Assays

by Zacks Equity Research

Hologic's (HOLX) two new molecular assays monitor transplant patients for EBV and BKV.

Haemonetics (HAE) Gains on Procedure Recovery Amid Cost Woes

by Zacks Equity Research

A strong procedure recovery in the hospital business, the resilience of blood donors in blood centers, and rollouts of Persona technology and NexSys aid Haemonetics (HAE).

Medtronic's (MDT) New JV With DaVita to Expand Renal Care Line

by Zacks Equity Research

NewCo is expected to operate successfully, leveraging Medtronic's (MDT) capabilities as a healthcare technology leader and DaVita's deep expertise as a comprehensive kidney care provider.